On this page: About the National Data | Methodology | History
About the National Data
Data
Baseline: 17.0 percent of adults aged 18 years and over with co-occurring substance use disorders and mental health disorders received both mental health care and specialty substance use treatment in 2022
Target: 19.7 percent
Methodology
Questions used to obtain the national baseline data
Please refer to the “Substance Dependence and Abuse” module, “Alcohol and Drug Treatment” module, and “Mental Health Services Utilization” module of the “2022 National Survey on Drug Use and Health (NSDUH): Final CAI Specifications for Programming” for the baseline questions of substance use disorder, substance use treatment and mental health treatment respectively.
Methodology notes
Substance use disorder (SUD) was defined as meeting criteria in the Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5), for one or more drugs or alcohol.
Any mental illness (AMI) among adults was defined as adults aged 18 or older who currently or at any time in the past year have had a diagnosable mental, behavioral, or emotional disorder as defined above, regardless of the level of impairment in carrying out major life activities. AMI was estimated based on a statistical model of a clinical diagnosis and responses to questions in the main NSDUH interview on distress (Kessler-6 scale), impairment (truncated version of the World Health Organization Disability Assessment Schedule), past year major depressive episode, past year suicidal thoughts, and age.
Mental health treatment in the past year was defined as the receipt of treatment or counseling for any problem with mental health, emotions, or behavior in the 12 months prior to the interview. Respondents were asked in the mental health services utilization section of the questionnaire to report whether they received mental health treatment in the past 12 months in an inpatient location, in an outpatient location, through the use of prescription medication, via telehealth treatment, or in a prison, jail, or juvenile detention center.
Respondents were classified as having received substance use treatment if they reported in the alcohol and drug treatment section of the questionnaire that they received treatment in the past 12 months for their use of alcohol or drugs in an inpatient location, in an outpatient location, via telehealth, or in a prison, jail, or juvenile detention center or that they received medication-assisted treatment for alcohol use or opioid use.
History
In 2024, due to the NSDUH adopting a multimode data collection method in 2021 and due to considerable revisions made to the mental health treatment questions on the 2022 survey, the baseline was revised from 3.4% in 2018 to 17.0% in 2022. The target was revised from 8.2% to 19.7% using the original target setting method.